Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pivotal trial of NovaCaps given green light by EMEA

Sep. 16, 2004

SPA for phase III study of glufosfamide for metastatic pancreatic cancer

Sep. 15, 2004

Iressa studied in new head-to-head trial for NSCLC

Sep. 15, 2004

Oncomer converts solitary tumor into bloodless mass

Sep. 15, 2004

AustCancer acquires North American rights to RP-101

Sep. 15, 2004

New phase IIIb study of Tarceva in advanced NSCLC

Sep. 15, 2004

Novel HDAC inhibitors prepared and tested at Oxford GlycoSciences

Sep. 15, 2004

Bonefos accepted for priority review

Sep. 14, 2004

Assessment of survival of advanced NSCLC patients treated with gefitinib

Sep. 13, 2004

Insmed's rhIGFBP-3 enters phase I study

Sep. 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...